SCPH (scPharmaceuticals, Inc.) יחס שווי שוק לשווי בספרים
This chart shows shares of scPharmaceuticals Inc. (SCPH), a recognized innovator in heart failure therapy offering convenient home infusion methods. The stability of pump and solution production is ensured by the functional equipment of partners and strict sterility control. The current metric stands at -14.12, while business growth relies on recognition by insurance companies and the availability of systems for non-hospital use.
%3A%20%D7%A9%D7%95%D7%95%D7%99%20%D7%A9%D7%95%D7%A7%20%D7%91%D7%99%D7%97%D7%A1%20%D7%9C%D7%A0%D7%9B%D7%A1%D7%99%D7%9D%20%D7%A0%D7%A7%D7%99%D7%99%D7%9D&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_SCPH_-_scPharmaceuticals-Inc._-_Market-Capitalization-to-Net-Assets "SCPH יחס שווי שוק לערך בספרים scPharmaceuticals (04.07.2022 - 18.10.2025) | 👁️GURU.Markets👁️")
פילוחי מדדים פיננסיים ומדדי שוק עבור scPharmaceuticals Inc. (SCPH)
The implementation of ESG standards in the production of infusion systems at scPharmaceuticals Inc. (SCPH) enhances resource management efficiency, which directly impacts the net asset value. An analysis of the company's P/B ratio allows for a comparison between the current market price and the book value, revealing the actual business discount and helping investors distinguish an undervalued asset from a value trap amidst market volatility.